Ksa Emea Point Of Care Poc Diagnostics Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030
Description
Saudi Arabia EMEA Point of Care (POC) Diagnostics Market Overview
The Saudi Arabia EMEA Point of Care (POC) Diagnostics Market is valued at USD 1.2 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of chronic diseases, a rising aging population, and advancements in diagnostic technologies that facilitate rapid testing and results. The demand for POC diagnostics is further fueled by the need for timely medical interventions and the convenience of testing in various settings. Key cities such as Riyadh, Jeddah, and Dammam dominate the market due to their advanced healthcare infrastructure and concentration of healthcare facilities. Riyadh, as the capital, is a hub for medical research and innovation, while Jeddah and Dammam benefit from their strategic locations and access to a large patient population, making them critical centers for POC diagnostics. In 2023, the Saudi Arabian government implemented a new regulation mandating the integration of POC testing in primary healthcare settings. This initiative aims to enhance early disease detection and improve patient outcomes, ensuring that healthcare providers are equipped with the necessary tools to deliver efficient and effective care.
Saudi Arabia EMEA Point of Care (POC) Diagnostics Market Segmentation
By Product Type: The product type segmentation includes various diagnostic kits and devices that cater to different medical needs. The subsegments are Blood-glucose monitoring kits, Cardio-metabolic monitoring kits, Pregnancy and fertility testing kits, Infectious disease testing kits, Cholesterol test strips, Hematology testing kits, and Others. Among these, Blood-glucose monitoring kits are leading the market due to the rising prevalence of diabetes and the increasing demand for home monitoring solutions. By Platform/Technology: This segmentation focuses on the various technologies used in POC diagnostics, including Lateral flow assays, Dipsticks, Microfluidics, Molecular diagnostics, Immunoassays, and Others. Lateral flow assays dominate this segment due to their simplicity, rapid results, and ease of use, making them ideal for both clinical and home settings.
Saudi Arabia EMEA Point of Care (POC) Diagnostics Market Competitive Landscape
The Saudi Arabia EMEA Point of Care (POC) Diagnostics Market is characterized by a dynamic mix of regional and international players. Leading participants such as Abbott Laboratories, F. Hoffmann-La Roche Ltd (Roche Diagnostics), Siemens Healthineers AG, Becton, Dickinson and Company, Cepheid (Danaher Corporation), bioMérieux SA, Beckman Coulter, Inc., Nova Biomedical Corporation, Alere Inc. (Abbott Rapid Diagnostics), QuidelOrtho Corporation, Sysmex Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Werfen, S.A., Randox Laboratories Ltd. contribute to innovation, geographic expansion, and service delivery in this space.
Abbott Laboratories
1888 Abbott Park, Illinois, USA
F. Hoffmann-La Roche Ltd 1896 Basel, Switzerland
Siemens Healthineers AG
1847 Munich, Germany
Becton, Dickinson and Company 1897 Franklin Lakes, New Jersey, USA
Cepheid (Danaher Corporation)
1996 Sunnyvale, California, USA
Company
Establishment Year
Headquarters
Regional revenue from POC diagnostics in Saudi Arabia
POC diagnostics revenue CAGR (Saudi Arabia)
Share of POC diagnostics in company’s total MEA revenue
Installed base of POC analyzers and devices in Saudi Arabia
Number of approved POC test menus/panels in Saudi Arabia
Market penetration in key end?user segments (hospitals, diagnostic centers, home care) The establishment years and headquarters locations shown for the listed companies are consistent with publicly available corporate histories, while the Saudi Arabia?specific revenue, installed base, and test?menu metrics remain blank because such granular figures are typically proprietary and not disclosed in open sources. For users of this table, these fields can be completed later using confidential vendor disclosures or paid market reports, ensuring respect for intellectual property and copyright restrictions when incorporating any non?public numerical data.
Saudi Arabia EMEA Point of Care (POC) Diagnostics Market Industry Analysis
Growth Drivers
Increasing Prevalence of Chronic Diseases: The rise in chronic diseases such as diabetes and cardiovascular conditions is a significant growth driver for the POC diagnostics market in Saudi Arabia. According to the World Health Organization, approximately 8 million adults in Saudi Arabia are living with diabetes as of future. This increasing prevalence necessitates frequent monitoring and rapid diagnostic solutions, thereby driving demand for POC diagnostics that can provide timely results and improve patient management. Rising Demand for Rapid Diagnostic Tests: The demand for rapid diagnostic tests has surged, particularly in response to the COVID-19 pandemic. In future, the Saudi Ministry of Health reported a 45% increase in the use of rapid tests for infectious diseases. This trend is expected to continue as healthcare providers seek efficient solutions to manage patient care, leading to a greater reliance on POC diagnostics that deliver quick and accurate results, enhancing overall healthcare delivery. Technological Advancements in POC Diagnostics: Technological innovations are transforming the POC diagnostics landscape, with advancements in microfluidics and biosensors enhancing test accuracy and speed. The Saudi Arabian government has invested over $600 million in healthcare technology development in future, fostering an environment conducive to innovation. These advancements not only improve diagnostic capabilities but also expand the range of tests available, driving market growth as healthcare providers adopt these new technologies.
Market Challenges
High Costs of Advanced Diagnostic Equipment: The high costs associated with advanced POC diagnostic equipment pose a significant challenge for market penetration. For instance, the average cost of sophisticated POC devices can exceed $12,000, making them less accessible for smaller healthcare facilities. This financial barrier limits the widespread adoption of POC technologies, particularly in rural areas where budget constraints are more pronounced, hindering overall market growth. Regulatory Hurdles in Product Approvals: Regulatory challenges significantly impact the POC diagnostics market in Saudi Arabia. The Saudi Food and Drug Authority (SFDA) has stringent approval processes that can delay the introduction of new diagnostic products. In future, the average time for product approval was reported to be over 14 months, which can deter companies from investing in the market. These regulatory hurdles can slow innovation and limit the availability of new diagnostic solutions.
Saudi Arabia EMEA Point of Care (POC) Diagnostics Market Future Outlook
The future of the POC diagnostics market in Saudi Arabia appears promising, driven by ongoing technological advancements and increasing healthcare investments. The integration of artificial intelligence in diagnostic processes is expected to enhance accuracy and efficiency, while the expansion of telemedicine services will facilitate remote patient monitoring. Additionally, the growing focus on preventive healthcare will likely drive demand for innovative POC solutions, positioning the market for significant growth in future.
Market Opportunities
Expansion of Telemedicine Services: The rapid expansion of telemedicine services presents a significant opportunity for POC diagnostics. With the Saudi government investing over $300 million in telehealth initiatives in future, healthcare providers can leverage POC technologies to offer remote testing solutions, improving patient access to diagnostics and enhancing overall healthcare delivery. Development of Innovative POC Diagnostic Products: There is a growing opportunity for the development of innovative POC diagnostic products tailored to local healthcare needs. With a projected increase in healthcare spending to $60 billion in future, companies can focus on creating customized solutions that address specific health challenges in Saudi Arabia, thereby capturing a larger market share.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
The Saudi Arabia EMEA Point of Care (POC) Diagnostics Market is valued at USD 1.2 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of chronic diseases, a rising aging population, and advancements in diagnostic technologies that facilitate rapid testing and results. The demand for POC diagnostics is further fueled by the need for timely medical interventions and the convenience of testing in various settings. Key cities such as Riyadh, Jeddah, and Dammam dominate the market due to their advanced healthcare infrastructure and concentration of healthcare facilities. Riyadh, as the capital, is a hub for medical research and innovation, while Jeddah and Dammam benefit from their strategic locations and access to a large patient population, making them critical centers for POC diagnostics. In 2023, the Saudi Arabian government implemented a new regulation mandating the integration of POC testing in primary healthcare settings. This initiative aims to enhance early disease detection and improve patient outcomes, ensuring that healthcare providers are equipped with the necessary tools to deliver efficient and effective care.
Saudi Arabia EMEA Point of Care (POC) Diagnostics Market Segmentation
By Product Type: The product type segmentation includes various diagnostic kits and devices that cater to different medical needs. The subsegments are Blood-glucose monitoring kits, Cardio-metabolic monitoring kits, Pregnancy and fertility testing kits, Infectious disease testing kits, Cholesterol test strips, Hematology testing kits, and Others. Among these, Blood-glucose monitoring kits are leading the market due to the rising prevalence of diabetes and the increasing demand for home monitoring solutions. By Platform/Technology: This segmentation focuses on the various technologies used in POC diagnostics, including Lateral flow assays, Dipsticks, Microfluidics, Molecular diagnostics, Immunoassays, and Others. Lateral flow assays dominate this segment due to their simplicity, rapid results, and ease of use, making them ideal for both clinical and home settings.
Saudi Arabia EMEA Point of Care (POC) Diagnostics Market Competitive Landscape
The Saudi Arabia EMEA Point of Care (POC) Diagnostics Market is characterized by a dynamic mix of regional and international players. Leading participants such as Abbott Laboratories, F. Hoffmann-La Roche Ltd (Roche Diagnostics), Siemens Healthineers AG, Becton, Dickinson and Company, Cepheid (Danaher Corporation), bioMérieux SA, Beckman Coulter, Inc., Nova Biomedical Corporation, Alere Inc. (Abbott Rapid Diagnostics), QuidelOrtho Corporation, Sysmex Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Werfen, S.A., Randox Laboratories Ltd. contribute to innovation, geographic expansion, and service delivery in this space.
Abbott Laboratories
1888 Abbott Park, Illinois, USA
F. Hoffmann-La Roche Ltd 1896 Basel, Switzerland
Siemens Healthineers AG
1847 Munich, Germany
Becton, Dickinson and Company 1897 Franklin Lakes, New Jersey, USA
Cepheid (Danaher Corporation)
1996 Sunnyvale, California, USA
Company
Establishment Year
Headquarters
Regional revenue from POC diagnostics in Saudi Arabia
POC diagnostics revenue CAGR (Saudi Arabia)
Share of POC diagnostics in company’s total MEA revenue
Installed base of POC analyzers and devices in Saudi Arabia
Number of approved POC test menus/panels in Saudi Arabia
Market penetration in key end?user segments (hospitals, diagnostic centers, home care) The establishment years and headquarters locations shown for the listed companies are consistent with publicly available corporate histories, while the Saudi Arabia?specific revenue, installed base, and test?menu metrics remain blank because such granular figures are typically proprietary and not disclosed in open sources. For users of this table, these fields can be completed later using confidential vendor disclosures or paid market reports, ensuring respect for intellectual property and copyright restrictions when incorporating any non?public numerical data.
Saudi Arabia EMEA Point of Care (POC) Diagnostics Market Industry Analysis
Growth Drivers
Increasing Prevalence of Chronic Diseases: The rise in chronic diseases such as diabetes and cardiovascular conditions is a significant growth driver for the POC diagnostics market in Saudi Arabia. According to the World Health Organization, approximately 8 million adults in Saudi Arabia are living with diabetes as of future. This increasing prevalence necessitates frequent monitoring and rapid diagnostic solutions, thereby driving demand for POC diagnostics that can provide timely results and improve patient management. Rising Demand for Rapid Diagnostic Tests: The demand for rapid diagnostic tests has surged, particularly in response to the COVID-19 pandemic. In future, the Saudi Ministry of Health reported a 45% increase in the use of rapid tests for infectious diseases. This trend is expected to continue as healthcare providers seek efficient solutions to manage patient care, leading to a greater reliance on POC diagnostics that deliver quick and accurate results, enhancing overall healthcare delivery. Technological Advancements in POC Diagnostics: Technological innovations are transforming the POC diagnostics landscape, with advancements in microfluidics and biosensors enhancing test accuracy and speed. The Saudi Arabian government has invested over $600 million in healthcare technology development in future, fostering an environment conducive to innovation. These advancements not only improve diagnostic capabilities but also expand the range of tests available, driving market growth as healthcare providers adopt these new technologies.
Market Challenges
High Costs of Advanced Diagnostic Equipment: The high costs associated with advanced POC diagnostic equipment pose a significant challenge for market penetration. For instance, the average cost of sophisticated POC devices can exceed $12,000, making them less accessible for smaller healthcare facilities. This financial barrier limits the widespread adoption of POC technologies, particularly in rural areas where budget constraints are more pronounced, hindering overall market growth. Regulatory Hurdles in Product Approvals: Regulatory challenges significantly impact the POC diagnostics market in Saudi Arabia. The Saudi Food and Drug Authority (SFDA) has stringent approval processes that can delay the introduction of new diagnostic products. In future, the average time for product approval was reported to be over 14 months, which can deter companies from investing in the market. These regulatory hurdles can slow innovation and limit the availability of new diagnostic solutions.
Saudi Arabia EMEA Point of Care (POC) Diagnostics Market Future Outlook
The future of the POC diagnostics market in Saudi Arabia appears promising, driven by ongoing technological advancements and increasing healthcare investments. The integration of artificial intelligence in diagnostic processes is expected to enhance accuracy and efficiency, while the expansion of telemedicine services will facilitate remote patient monitoring. Additionally, the growing focus on preventive healthcare will likely drive demand for innovative POC solutions, positioning the market for significant growth in future.
Market Opportunities
Expansion of Telemedicine Services: The rapid expansion of telemedicine services presents a significant opportunity for POC diagnostics. With the Saudi government investing over $300 million in telehealth initiatives in future, healthcare providers can leverage POC technologies to offer remote testing solutions, improving patient access to diagnostics and enhancing overall healthcare delivery. Development of Innovative POC Diagnostic Products: There is a growing opportunity for the development of innovative POC diagnostic products tailored to local healthcare needs. With a projected increase in healthcare spending to $60 billion in future, companies can focus on creating customized solutions that address specific health challenges in Saudi Arabia, thereby capturing a larger market share.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
Table of Contents
100 Pages
- 1. Ksa Emea Point Of Care Poc Diagnostics Size, Share, Growth Drivers, Trends, Opportunities & – Market Overview
- 1.1. Definition and Scope
- 1.2. Market Taxonomy
- 1.3. Market Growth Rate
- 1.4. Market Segmentation Overview
- 2. Ksa Emea Point Of Care Poc Diagnostics Size, Share, Growth Drivers, Trends, Opportunities & – Market Size (in USD Bn), 2019–2024
- 2.1. Historical Market Size
- 2.2. Year-on-Year Growth Analysis
- 2.3. Key Market Developments and Milestones
- 3. Ksa Emea Point Of Care Poc Diagnostics Size, Share, Growth Drivers, Trends, Opportunities & – Market Analysis
- 3.1. Growth Drivers
- 3.1.1. Increasing prevalence of chronic diseases
- 3.1.2. Rising demand for rapid diagnostic tests
- 3.1.3. Technological advancements in POC diagnostics
- 3.1.4. Growing healthcare expenditure in Saudi Arabia
- 3.2. Restraints
- 3.2.1. High costs of advanced diagnostic equipment
- 3.2.2. Regulatory challenges in product approvals
- 3.2.3. Limited awareness among healthcare providers
- 3.2.4. Competition from traditional laboratory testing
- 3.3. Opportunities
- 3.3.1. Expansion of telemedicine and remote diagnostics
- 3.3.2. Increasing investments in healthcare infrastructure
- 3.3.3. Development of innovative POC diagnostic solutions
- 3.3.4. Partnerships with local healthcare providers
- 3.4. Trends
- 3.4.1. Shift towards home-based healthcare solutions
- 3.4.2. Integration of AI and machine learning in diagnostics
- 3.4.3. Focus on personalized medicine and patient-centric care
- 3.4.4. Growing emphasis on preventive healthcare measures
- 3.5. Government Regulation
- 3.5.1. Compliance with Saudi Food and Drug Authority (SFDA) guidelines
- 3.5.2. Standards for medical device registration and approval
- 3.5.3. Regulations on quality control and safety of diagnostics
- 3.5.4. Policies promoting local manufacturing of medical devices
- 3.6. SWOT Analysis
- 3.7. Stakeholder Ecosystem
- 3.8. Competition Ecosystem
- 4. Ksa Emea Point Of Care Poc Diagnostics Size, Share, Growth Drivers, Trends, Opportunities & – Market Segmentation, 2024
- 4.1. By Product Type (in Value %)
- 4.1.1. Glucose Monitoring Devices
- 4.1.2. Infectious Disease Testing Kits
- 4.1.3. Cardiac Markers
- 4.1.4. Coagulation Testing Devices
- 4.1.5. Others
- 4.2. By Application (in Value %)
- 4.2.1. Diabetes Management
- 4.2.2. Cardiovascular Diseases
- 4.2.3. Infectious Diseases
- 4.2.4. Pregnancy and Fertility Testing
- 4.3. By End-User (in Value %)
- 4.3.1. Hospitals
- 4.3.2. Home Healthcare
- 4.3.3. Diagnostic Laboratories
- 4.4. By Distribution Channel (in Value %)
- 4.4.1. Direct Sales
- 4.4.2. Distributors
- 4.4.3. Online Sales
- 4.5. By Region (in Value %)
- 4.5.1. Central Region
- 4.5.2. Eastern Region
- 4.5.3. Western Region
- 4.5.4. Southern Region
- 4.5.5. Northern Region
- 4.6. By Others (in Value %)
- 5. Ksa Emea Point Of Care Poc Diagnostics Size, Share, Growth Drivers, Trends, Opportunities & – Market Cross Comparison
- 5.1. Detailed Profiles of Major Companies
- 5.1.1. Abbott Laboratories
- 5.1.2. Roche Diagnostics
- 5.1.3. Siemens Healthineers
- 5.1.4. Becton, Dickinson and Company
- 5.1.5. Cepheid
- 5.2. Cross Comparison Parameters
- 5.2.1. No. of Employees
- 5.2.2. Headquarters
- 5.2.3. Inception Year
- 5.2.4. Revenue
- 5.2.5. Product Portfolio
- 6. Ksa Emea Point Of Care Poc Diagnostics Size, Share, Growth Drivers, Trends, Opportunities & – Market Regulatory Framework
- 6.1. Medical Device Standards
- 6.2. Compliance Requirements and Audits
- 6.3. Certification Processes
- 7. Ksa Emea Point Of Care Poc Diagnostics Size, Share, Growth Drivers, Trends, Opportunities & – Market Future Size (in USD Bn), 2025–2030
- 7.1. Future Market Size Projections
- 7.2. Key Factors Driving Future Market Growth
- 8. Ksa Emea Point Of Care Poc Diagnostics Size, Share, Growth Drivers, Trends, Opportunities & – Market Future Segmentation, 2030
- 8.1. By Product Type (in Value %)
- 8.2. By Application (in Value %)
- 8.3. By End-User (in Value %)
- 8.4. By Distribution Channel (in Value %)
- 8.5. By Region (in Value %)
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
